Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis

Published:2023-09 Issue:5 Volume:53 Page:706-718
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Jeet Varinder^ORCID,Parkinson Bonny^ORCID,Song Rachel^ORCID,Sharma Rajan^ORCID,Hoyle Martin

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference40 articles.

1. global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study, United States;Steele;Cancer,2017

3. EAU-ESTRO-SIOG Guidelines on prostate cancer. part 1: Screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

4. Guideline of guidelines: Imaging of localized prostate cancer;Wollin;BJU Int,2015

5. Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice;Salminen;Acta Oncol,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy;Diagnostics;2024-09-05

2. Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen;Current Oncology;2024-07-24

3. Editorial for “Added Value of [18F]PSMA‐1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management”;Journal of Magnetic Resonance Imaging;2024-05-07

4. PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy;The Cancer Journal;2024-05

5. Agreement between PSMA-RADS and E-PSMA systems in classifying [18F]PSMA-1007 PET/CT lesions among prostate cancer patients: exploring the correlation between lesion size and uptake;Frontiers in Medicine;2024-03-12